Northern Leaf has partnered with Canadian biotech firm 3R Biotech to open 3R Europe, a facility combining cannabis plant testing,
Switzerland has granted approval for a new five-year, 5000-participant adult-use cannabis pilot trial, marking the eighth since the groundbreaking project
Ireland’s Oireachtas Joint Committee on Drugs Use has recommended the full decriminalisation of personal possession of all drugs, calling on
In the weeks since cannabis under a state medical licence was moved to Schedule III, US multi-state operators (MSOs) have
Written by Oskar Fletcher, Chief Executive of pharmaceutical contract manufacturing operator Blossom Pharma. Europe’s medical cannabis industry is entering a
There is a frustrating misimpression circulating in the cannabis community regarding rescheduling. Many headlines state that Trump is considering finishing
The Committee on Herbal Medicinal Products (HMPC) of the European Medicines Agency (EMA) published a draft opinion on July 09,
In this special edition of the Business of Cannabis Podcast, Tim Kirby, CEO of Releaf, sits down with Professor Chris Shambrook, renowned performance psychologist and long-time advisor to the British Olympic rowing team.
In today’s crowded cannabis landscape, where “premium” is often used as a buzzword, The Medocann Group is setting a higher
Nearly 80% of Canadian’s now source their cannabis solely from the legal market, marking a stark shift away from the illicit market seven years after legalisation.
Cannabis stocks across North America have skyrocketed to their highest point so far this year, despite a lukewarm promise from
In the first of a series of interviews focused on the expert contributors to Prohibition Partners’ newly launched Insights Hub, we sat down with Linnea to discuss the increasing importance of GMP certification and pharmaceutical discipline in a rapidly growing cannabis market.
In Germany, the partial legalisation of cannabis has opened up a new telemedicine market. Instead of visiting a doctor in person, patients can now request prescriptions online, with cannabis flowers sent directly to patients via specialist pharmacies.
The cannabis industry is once again awash with hope and speculation over the promise of rescheduling following reports that President Trump has promised the industry that ‘it’s something we’re going to look at’.
You can also read this story in German, here. When the Cannabis Act came into force in Germany, the aim
Over 100 legal New York cannabis dispensaries could be forced to relocate following a monumental blunder from the state’s Office of Cannabis Management (OCM).
Slovenia is making its own move toward legalisation, at least in part, for personal consumption. As reported two weeks ago by the Slovenian news agency Index, members of Slovenia’s governing coalition, comprising the Freedom Movement (Gibanje Svoboda) and the Left (Levica), have submitted a draft bill to parliament aimed at regulating personal cannabis use. Natasa Sukic, a member of parliament from Levica, said the goal is to implement the will of the voters.
Two years after launching its first pilot projects for the regulated distribution of recreational cannabis, Switzerland is now laying the groundwork for full national reform.
We won’t spam you
